MA
IRON icon

MYDA Advisors’s Disc Medicine IRON Stock Holding History

MYDA Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,100
Closed -$103K – 102
2022
Q3 		$103K Buy
2,100
+1,433
+215% +$67.6K 0.05% 135
2022
Q2 		$34K Buy
+667
New +$29.5K 0.01% 177
2021
Q2 		– Sell
-2,130
Closed -$866K – 309
2021
Q1 		$866K Buy
+2,130
New +$950K 0.24% 131

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MYDA Advisors's IRON Position: Q4 2022 in Review

MYDA Advisors sold out of Disc Medicine (IRON) in Q4 2022, closing a stake of 2,100 shares — an estimated $103K sold.

MYDA Advisors first reported a position in IRON in Q1 2021 and held it in 3 quarters. The position peaked at $866K in Q1 2021. 35 funds tracked by Wall St. Rank hold IRON as of Q4 2022.

  • MYDA Advisors reported no remaining Disc Medicine position as of Q4 2022 after selling out during the quarter.
  • MYDA Advisors sold 2,100 Disc Medicine shares in Q4 2022, an estimated $103K.
  • MYDA Advisors first reported a position in Disc Medicine in Q1 2021 and held it in 3 quarters.
  • MYDA Advisors's Disc Medicine position peaked at $866K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2022.

Based on MYDA Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.